Truepoint Inc. Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Truepoint Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 45.2% in the 3rd quarter, Holdings Channel reports. The firm owned 1,082 shares of the healthcare conglomerate’s stock after acquiring an additional 337 shares during the quarter. Truepoint Inc.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. KKM Financial LLC grew its holdings in UnitedHealth Group by 5.2% during the 3rd quarter. KKM Financial LLC now owns 5,233 shares of the healthcare conglomerate’s stock valued at $3,060,000 after buying an additional 259 shares in the last quarter. Algert Global LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $1,763,000. Canopy Partners LLC grew its holdings in UnitedHealth Group by 1.9% during the 3rd quarter. Canopy Partners LLC now owns 4,450 shares of the healthcare conglomerate’s stock valued at $2,602,000 after buying an additional 81 shares in the last quarter. Kingsview Wealth Management LLC grew its holdings in UnitedHealth Group by 4.1% during the 3rd quarter. Kingsview Wealth Management LLC now owns 10,461 shares of the healthcare conglomerate’s stock valued at $6,116,000 after buying an additional 416 shares in the last quarter. Finally, Alesco Advisors LLC grew its holdings in shares of UnitedHealth Group by 4.1% during the third quarter. Alesco Advisors LLC now owns 554 shares of the healthcare conglomerate’s stock worth $324,000 after purchasing an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on UNH shares. Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Barclays cut their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Stephens cut their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $590.87 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $543.77 billion, a PE ratio of 38.49, a P/E/G ratio of 1.75 and a beta of 0.58. The business has a 50 day moving average of $582.63 and a 200 day moving average of $552.95. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.56 earnings per share. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.